360 related articles for article (PubMed ID: 18063067)
1. Does the presence of additional thyroid nodules on ultrasound alter the risk of malignancy in patients with a follicular neoplasm of the thyroid?
Sippel RS; Elaraj DM; Khanafshar E; Kebebew E; Duh QY; Clark OH
Surgery; 2007 Dec; 142(6):851-7; discussion 857.e1-2. PubMed ID: 18063067
[TBL] [Abstract][Full Text] [Related]
2. Thyroid cancer in the thyroid nodules evaluated by ultrasonography and fine-needle aspiration cytology.
Lin JD; Chao TC; Huang BY; Chen ST; Chang HY; Hsueh C
Thyroid; 2005 Jul; 15(7):708-17. PubMed ID: 16053388
[TBL] [Abstract][Full Text] [Related]
3. Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.
Batawil N; Alkordy T
Eur J Surg Oncol; 2014 Feb; 40(2):182-6. PubMed ID: 24373298
[TBL] [Abstract][Full Text] [Related]
4. Validation of American Thyroid Association Ultrasound Risk Assessment of Thyroid Nodules Selected for Ultrasound Fine-Needle Aspiration.
Tang AL; Falciglia M; Yang H; Mark JR; Steward DL
Thyroid; 2017 Aug; 27(8):1077-1082. PubMed ID: 28657511
[TBL] [Abstract][Full Text] [Related]
5. A risk model to determine surgical treatment in patients with thyroid nodules with indeterminate cytology.
Macias CA; Arumugam D; Arlow RL; Eng OS; Lu SE; Javidian P; Davidov T; Trooskin SZ
Ann Surg Oncol; 2015 May; 22(5):1527-32. PubMed ID: 25388058
[TBL] [Abstract][Full Text] [Related]
6. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
7. Thyroid Nodule Size at Ultrasound as a Predictor of Malignancy and Final Pathologic Size.
Cavallo A; Johnson DN; White MG; Siddiqui S; Antic T; Mathew M; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
Thyroid; 2017 May; 27(5):641-650. PubMed ID: 28052718
[TBL] [Abstract][Full Text] [Related]
8. The frequency of malignancy and the relationship between malignancy and ultrasonographic features of thyroid nodules with indeterminate cytology.
Tutuncu Y; Berker D; Isik S; Akbaba G; Ozuguz U; Kucukler FK; Göcmen E; Yalcın Y; Aydin Y; Guler S
Endocrine; 2014 Feb; 45(1):37-45. PubMed ID: 23504651
[TBL] [Abstract][Full Text] [Related]
9. Role of surgeon-performed ultrasound in predicting malignancy in patients with indeterminate thyroid nodules.
Méndez W; Rodgers SE; Lew JI; Montano R; Solórzano CC
Ann Surg Oncol; 2008 Sep; 15(9):2487-92. PubMed ID: 18622644
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules.
Sahin M; Gursoy A; Tutuncu NB; Guvener DN
Clin Endocrinol (Oxf); 2006 Oct; 65(4):514-8. PubMed ID: 16984245
[TBL] [Abstract][Full Text] [Related]
11. Concordance between thyroid nodule sizes measured by ultrasound and gross pathology examination: effect on patient management.
Deveci MS; Deveci G; LiVolsi VA; Gupta PK; Baloch ZW
Diagn Cytopathol; 2007 Sep; 35(9):579-83. PubMed ID: 17703450
[TBL] [Abstract][Full Text] [Related]
12. Predictors of malignancy in patients with cytologically suspicious thyroid nodules.
Castro MR; Espiritu RP; Bahn RS; Henry MR; Gharib H; Caraballo PJ; Morris JC
Thyroid; 2011 Nov; 21(11):1191-8. PubMed ID: 22007937
[TBL] [Abstract][Full Text] [Related]
13. Is an Increase in Thyroid Nodule Volume a Risk Factor for Malignancy?
Nakamura H; Hirokawa M; Ota H; Kihara M; Miya A; Miyauchi A
Thyroid; 2015 Jul; 25(7):804-11. PubMed ID: 25872408
[TBL] [Abstract][Full Text] [Related]
14. Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients.
Rago T; Di Coscio G; Basolo F; Scutari M; Elisei R; Berti P; Miccoli P; Romani R; Faviana P; Pinchera A; Vitti P
Clin Endocrinol (Oxf); 2007 Jan; 66(1):13-20. PubMed ID: 17201796
[TBL] [Abstract][Full Text] [Related]
15. Fine-needle aspiration biopsies in the management of indeterminate follicular and Hurthle cell thyroid lesions.
Mijović T; Rochon L; Gologan O; Hier MP; Black MJ; Young J; Payne RJ
Otolaryngol Head Neck Surg; 2009 May; 140(5):715-9. PubMed ID: 19393417
[TBL] [Abstract][Full Text] [Related]
16. Thyroid nodule size and prediction of cancer.
Kamran SC; Marqusee E; Kim MI; Frates MC; Ritner J; Peters H; Benson CB; Doubilet PM; Cibas ES; Barletta J; Cho N; Gawande A; Ruan D; Moore FD; Pou K; Larsen PR; Alexander EK
J Clin Endocrinol Metab; 2013 Feb; 98(2):564-70. PubMed ID: 23275525
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors of malignancy in patients with cytologically suspicious for Hurthle cell neoplasm of thyroid nodules.
Lee KH; Shin JH; Ko ES; Hahn SY; Kim JS; Kim JH; Oh YL
Int J Surg; 2013; 11(9):898-902. PubMed ID: 23916366
[TBL] [Abstract][Full Text] [Related]
18. Malignancy risk for solitary and multiple nodules in Hürthle cell-predominant thyroid fine-needle aspirations: A multi-institutional study.
Wong KS; Jo VY; Lowe AC; Faquin WC; Renshaw AA; Shah AA; Roh MH; Stelow EB; Krane JF
Cancer Cytopathol; 2020 Jan; 128(1):68-75. PubMed ID: 31751003
[TBL] [Abstract][Full Text] [Related]
19. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm.
Sorrenti S; Trimboli P; Catania A; Ulisse S; De Antoni E; D'Armiento M
Thyroid; 2009 Apr; 19(4):355-60. PubMed ID: 19355826
[TBL] [Abstract][Full Text] [Related]
20. Role of cytological and ultrasonographic features in predicting the risk of malignancy in thyroid nodules with indeterminate cytology.
Saiegh L; Shechner C; Dickstein G; Sheikh-Ahmad M; Reut M; Odeh M; Toubi A; Bejar J
Minerva Endocrinol; 2014 Mar; 39(1):43-52. PubMed ID: 24513603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]